Skip to content
Certified ManufacturersFor manufacturers

Unique Encapsulation Technology LLC

Landing, NJ, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Unique Encapsulation Technology LLC is a dietary supplement manufacturer in Landing, NJ, United States, certified to NSF/ANSI 455-2 GMP, with 2 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules.

Facilities listed
2
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (2)

  • 186 Goldmine Road, Flanders, NJ 07836, United States

    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Quality Unit Operations
  • 9 Lenel Road, Landing, NJ 07850, United States

    • Encapsulation
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Warehousing

How Unique Encapsulation Technology LLC compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name Unique Encapsulation Technology LLC in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 4 food or dietary supplement inspections at facilities matching Unique Encapsulation Technology LLC, from 2016 to 2024, as of . 2 found no objectionable conditions, 1 found conditions the firm was left to correct, and 1 led FDA to recommend official action.

  • No action indicated · No objectionable conditions found

    Inspected

    Landing, New Jersey

    FEI 3009748303

  • No action indicated · No objectionable conditions found

    Inspected

    Landing, New Jersey

    FEI 3009748303

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Landing, New Jersey

    7 citations posted:

    • Tests, examinations - scientifically valid (21 CFR 111.75(h))
    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))
    • Batch record - follow master (21 CFR 111.255(c))
    See all 7 citations
    • Tests, examinations - scientifically valid (21 CFR 111.75(h))

      You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.

    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))

      Your quality control personnel did not approve or reject deviations or modifications that may affect the identity, purity, strength, or composition of a dietary supplement.

    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))

      Your quality control personnel did not reject a dietary supplement when an established specification was not met.

    • Batch record - follow master (21 CFR 111.255(c))

      Your batch production record did not accurately follow the appropriate master manufacturing record.

    • Laboratory operations: electronic (21 CFR 111.325(a))

      Your electronic records for your laboratory operations do not comply with the electronic records requirements.

    • Document; laboratory methodology followed (21 CFR 111.325(b)(2)(i))

      The person who conducted the testing and examination did not document at the time of performance that established laboratory methodology was followed.

    • Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))

      The written record of a product complaint did not include the findings of the investigation and follow-up action taken.

    FEI 3009748303

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Landing, New Jersey

    8 citations posted:

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
    • Specifications met - verify; finished batch (21 CFR 111.75(c))
    See all 8 citations
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity , strength and composition.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for purity, strength, composition and limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement.

    • Specifications met - test, examinations; compliance (21 CFR 111.75(c)(2))

      You did not conduct appropriate tests or examinations to determine compliance with the specifications established for strength.

    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))

      Your quality control personnel did not reject a component and dietary supplement when an established specification was not met.

    • Written procedures - tests, examinations; specifications met (21 CFR 111.303)

      You did not follow written procedures for the tests and examinations conducted to determine whether specifications are met.

    • Document; laboratory methodology followed (21 CFR 111.325(b)(2)(i))

      The person who conducted the testing and examination did not document at the time of performance that established laboratory methodology was followed.

    FEI 3009748303

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 2 facility addresses
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026